Please download the dossier by clicking on the dossier button x
×

Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors

  • US 9,480,693 B2
  • Filed: 09/10/2015
  • Issued: 11/01/2016
  • Est. Priority Date: 02/14/2013
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a disorder or a disease associated with neutral endopeptidase activity in a subject in need thereof, comprising:

  • administering to the subject a therapeutically effective amount of a compound of the formula (I);

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×